Rezaei N - Search Results

1

The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury.

Torabi S, Bahreini F, Rezaei N. Torabi S, et al. Among authors: rezaei n. Acta Biomed. 2020 Nov 10;91(4):e2020142. doi: 10.23750/abm.v91i4.10159. Acta Biomed. 2020. PMID: 33525252 Free PMC article. Review.

2

microRNA-related single-nucleotide polymorphisms and breast cancer.

Bahreini F, Rayzan E, Rezaei N. Bahreini F, et al. Among authors: rezaei n. J Cell Physiol. 2021 Mar;236(3):1593-1605. doi: 10.1002/jcp.29966. Epub 2020 Jul 27. J Cell Physiol. 2021. PMID: 32716070 Review.

3

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting.

Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N. Sharifkashani S, et al. Among authors: rezaei n. Eur J Pharmacol. 2020 Oct 5;884:173455. doi: 10.1016/j.ejphar.2020.173455. Epub 2020 Jul 31. Eur J Pharmacol. 2020. PMID: 32745604 Free PMC article. Review.

4

Cardiovascular system is at higher risk of affecting by COVID-19.

Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Nejadghaderi SA, et al. Among authors: rezaei n. Acta Biomed. 2020 Sep 7;91(3):e2020018. doi: 10.23750/abm.v91i3.9718. Acta Biomed. 2020. PMID: 32921715 Free PMC article. Review.

5

Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?

Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Palit P, et al. Among authors: rezaei n. Phytomedicine. 2021 May;85:153396. doi: 10.1016/j.phymed.2020.153396. Epub 2020 Oct 28. Phytomedicine. 2021. PMID: 33380375 Free PMC article. Review.

6

MicroRNAs and Diabetes Mellitus Type 1.

Bahreini F, Rayzan E, Rezaei N. Bahreini F, et al. Among authors: rezaei n. Curr Diabetes Rev. 2022;18(2):e021421191398. doi: 10.2174/1573399817666210215111201. Curr Diabetes Rev. 2022. PMID: 33588736 Review.

7

Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19.

Shakerian N, Mofateh R, Saghazadeh A, Rezaei N, Rezaei N. Shakerian N, et al. Among authors: rezaei n. Acta Biomed. 2020 Nov 10;92(1):e2021020. doi: 10.23750/abm.v92i1.10289. Acta Biomed. 2020. PMID: 33682807 Free PMC article.

8

ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.

Ahmadi M, Pashangzadeh S, Mousavi P, Saffarzadeh N, Amin Habibi M, Hajiesmaeili F, Rezaei N. Ahmadi M, et al. Among authors: rezaei n. Int Immunopharmacol. 2021 Jun;95:107568. doi: 10.1016/j.intimp.2021.107568. Epub 2021 Mar 22. Int Immunopharmacol. 2021. PMID: 33765612 Free PMC article.

9

Geriatrics and COVID-19.

Mirbeyk M, Saghazadeh A, Rezaei N. Mirbeyk M, et al. Among authors: rezaei n. Adv Exp Med Biol. 2021;1318:209-222. doi: 10.1007/978-3-030-63761-3_13. Adv Exp Med Biol. 2021. PMID: 33973181 Review.

10

COVID-19 in Patients with Hypertension.

Quinaglia T, Shabani M, Rezaei N. Quinaglia T, et al. Among authors: rezaei n. Adv Exp Med Biol. 2021;1318:243-261. doi: 10.1007/978-3-030-63761-3_15. Adv Exp Med Biol. 2021. PMID: 33973183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,582 results

Search Page